Calimmune's Acquisition

Calimmune was acquired by CSL Behring LLC on August 28, 2017.

Calimmune is a clinical-stage biotechnology company focused on developing novel gene therapies that have the potential to improve and protect the lives of patients by enhancing their immune systems. C…

Articles about Calimmune's Acquisition: